ACS
MEDP icon

Archford Capital Strategies’s Medpace MEDP Stock Holding History

Archford Capital Strategies’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$878K Buy
1,658
+85
+5% +$39.2K 0.09% 185
2026
Q1 		$755K Sell
1,573
-117
-7% -$59.9K 0.09% 195
2025
Q4 		$949K Buy
+1,690
New +$959K 0.11% 167

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Archford Capital Strategies's MEDP Position: Q2 2026 in Review

Archford Capital Strategies increased its Medpace (MEDP) stake by 5.4% in Q2 2026, buying an estimated $39.2K and bringing the position to 1,658 shares worth $878K. The position accounts for 0.09% of the portfolio, ranked #185.

Archford Capital Strategies first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $949K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Archford Capital Strategies held 1,658 shares of Medpace worth $878K as of Q2 2026.
  • Archford Capital Strategies bought 85 Medpace shares in Q2 2026, an estimated $39.2K.
  • Medpace made up 0.09% of Archford Capital Strategies's portfolio in Q2 2026, its #185 holding.
  • Archford Capital Strategies first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Archford Capital Strategies's Medpace position peaked at $949K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.